BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9092517)

  • 21. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.
    Li J; Brasier AR
    Mol Endocrinol; 1996 Mar; 10(3):252-64. PubMed ID: 8833654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons.
    Maggirwar SB; Sarmiere PD; Dewhurst S; Freeman RS
    J Neurosci; 1998 Dec; 18(24):10356-65. PubMed ID: 9852573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
    Mukhopadhyay A; Manna SK; Aggarwal BB
    J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis.
    Bourcier T; Sukhova G; Libby P
    J Biol Chem; 1997 Jun; 272(25):15817-24. PubMed ID: 9188479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of Fc gamma R receptors induces monocyte chemoattractant protein-1 in the human monocytic cell line THP-1 by a mechanism involving I kappa B-alpha degradation and formation of p50/p65 NF-kappa B/Rel complexes.
    Alonso A; Bayón Y; Renedo M; Crespo MS
    Int Immunol; 2000 Apr; 12(4):547-54. PubMed ID: 10744656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase C-dependent activation of NF-kappaB in enterocytes is independent of IkappaB degradation.
    Wilson L; Szabó C; Salzman AL
    Gastroenterology; 1999 Jul; 117(1):106-14. PubMed ID: 10381916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
    Sun SC; Ganchi PA; Béraud C; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1346-50. PubMed ID: 8108414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival.
    Koulich E; Nguyen T; Johnson K; Giardina C; D'mello S
    J Neurochem; 2001 Feb; 76(4):1188-98. PubMed ID: 11181838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
    Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
    Tewari M; Dobrzanski P; Mohn KL; Cressman DE; Hsu JC; Bravo R; Taub R
    Mol Cell Biol; 1992 Jun; 12(6):2898-908. PubMed ID: 1588976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.
    Latimer M; Ernst MK; Dunn LL; Drutskaya M; Rice NR
    Mol Cell Biol; 1998 May; 18(5):2640-9. PubMed ID: 9566883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator.
    Brasier AR; Li J; Wimbish KA
    Hypertension; 1996 Apr; 27(4):1009-17. PubMed ID: 8613256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Belich MP; Salmerón A; Johnston LH; Ley SC
    Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
    Lin R; Beauparlant P; Makris C; Meloche S; Hiscott J
    Mol Cell Biol; 1996 Apr; 16(4):1401-9. PubMed ID: 8657113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
    Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcription.
    Hansen SK; Baeuerle PA; Blasi F
    Mol Cell Biol; 1994 Apr; 14(4):2593-603. PubMed ID: 8139561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
    Bergmann MW; Loser P; Dietz R; von Harsdorf R
    J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F; Carrasco D; Bravo R
    Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.
    Sachdev S; Hannink M
    Mol Cell Biol; 1998 Sep; 18(9):5445-56. PubMed ID: 9710628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.